New weight-loss pill might help in the fight against obesity

For story suggestions or custom animation requests, contact [email protected] Visit http://archive.nextanimationstudio.com to view News Direct's complete archive of 3D news animations.

RESTRICTIONS: Broadcast: NO USE JAPAN, NO USE TAIWAN Digital: NO USE JAPAN, NO USE TAIWAN
A new study published in the New England Journal of Medicine has found promising results for a weight-loss drug in the U.S.

Researchers say lorcaserin, also known under the trade name of Belviq in the U.S., [a][b]is the first drug for weight-loss that does not increase the risk of heart issues.

Half of the 12,000 participants in the study were given lorcaserin, which is designed to suppress appetite, while the other half were given a placebo.

The drug is supposed to be taken twice a day and will would stimulate brain chemicals to bring about a feeling of fullness.

However, the researchers noted that side effects such as headaches and nausea may also be caused by the drug.

After 40 months, the study found that the participants prescribed lorcaserin were three times more likely to lose 5 to 10 percent of their body weight compared to those taking a placebo.

However, according an editorial published in the New England Journal of Medicine, patients are advised to use the drugs on a "cautious basis" based on their needs.

RUNDOWN SHOWS:
1. Lorcaserin is shown in a bottle, along with a depiction of the drug being deemed safe for the heart.
2. Two of the lorcaserin drugs as well as the brain getting stimulated are shown.
3. Side effects of lorcaserin are shown.
4. A depiction of the drug being ingested and a chart showing the body weight reducing by five to ten percent.

VOICEOVER (in English):
"The researchers involved claim lorcaserin, which is known under the trade name of Belviq in the U.S., is the first drug for weight-loss deemed safe for the heart."

"The drug is supposed to be taken twice a day and will would stimulate brain chemicals to bring about a feeling of fullness."
"However, the researchers noted that side effects such as headaches and nausea may also be caused by the drug."

"After 40 months, the study found that the participants who were prescribed lorcaserin were three times more likely to lose 5 to 10 percent of their body weight compared to those taking a placebo."

SOURCES: The Guardian, The New England Journal of Medicine, The BBC, Reuters, The Atlanta Journal-Constitution, Associated Press
https://www.theguardian.com/society/2018/aug/27/weight-loss-drug-belviq-not-linked-to-heart-problems-finds-study

https://www.nejm.org/doi/full/10.1056/NEJMoa1808721

https://www.bbc.co.uk/news/health-45319393

https://www.reuters.com/article/us-health-belviq-safety/weight-loss-drug-lorcaserin-found-safe-in-large-study-idUSKCN1LC2C1

https://www.ajc.com/news/health-med-fit-science/this-weight-loss-drug-the-first-succeed-without-heart-risks-study-finds/cFh0YIJSs4bfuMpEsnxpPN/

https://apnews.com/5bcf5229e462469cb150cdb67c9c9beb/Weight-loss-drug-Belviq-seems-safe-for-heart,-study-finds